Get started
Author

Youhei Fujiki

Observed names: FUJIKI, Youhei, Y Fujiki, Y. Fujiki
ORCID: 0000-0002-6071-4115
Observed ORCID: 0000-0002-6071-4115
OpenAlex ID: A5047014046
Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients
2017 · Youhei Fujiki, Takuya Kotani, et al. · Modern Rheumatology · 95
Exploration of pathomechanism using comprehensive analysis of serum cytokines in polymyositis/dermatomyositis-interstitial lung disease
2019 · Shogo Matsuda, Takuya Kotani, et al. · Rheumatology · 45
CCL2 produced by CD68+/CD163+ macrophages as a promising clinical biomarker of microscopic polyangiitis-interstitial lung disease
2021 · Shogo Matsuda, Takuya Kotani, et al. · Rheumatology · 36
Evaluation of poor prognostic factors of respiratory related death in microscopic polyangiitis complicated by interstitial lung disease
2021 · Shogo Matsuda, Takuya Kotani, et al. · Scientific Reports · 29
PDF
Successful multi‐target therapy including rituximab and mycophenolate mofetil in anti‐melanoma differentiation‐associated gene 5 antibody‐positive rapidly progressive interstitial lung disease with clinically amyopathic dermatomyositis
2017 · Jumpei Hisanaga, Takuya Kotani, et al. · International Journal of Rheumatic Diseases · 25
PDF
Successful treatment with intravenous high‐dose immunoglobulin for cardiomyopathy in dermatomyositis complicated with rapid progressive interstitial pneumonia
2015 · Yuki Yoshimatsu, Takuya Kotani, et al. · International Journal of Rheumatic Diseases · 20
Pre-pregnancy serum complement C3 level is a predictor of preterm birth for pregnancies with systemic lupus erythematosus
2021 · Yuri Hiramatsu, Kentaro Isoda, et al. · Arthritis Research & Therapy · 19
PDF
Efficacy and safety of oral high‐trough level tacrolimus in acute/subacute interstitial pneumonia with dermatomyositis
2018 · Takayasu Suzuka, Takuya Kotani, et al. · International Journal of Rheumatic Diseases · 19
Therapeutic drug monitoring of cyclosporine microemulsion in interstitial pneumonia with dermatomyositis
2010 · Koji Nagai, Tohru Takeuchi, et al. · Modern Rheumatology · 18
Initial limited three-level thin-section computed tomography scorings predict the prognosis of acute/subacute interstitial pneumonia in patients with dermatomyositis
2015 · Takuya Kotani, Tohru Takeuchi, et al. · Modern Rheumatology · 17
Eosinophilic granulomatosis with polyangiitis complicated by subarachnoid hemorrhage and coronary vasculitis: a case report and review of the literature
2017 · Shogo Matsuda, Shuzo Yoshida, et al. · Rheumatology International · 16
Aggressive multi‐combination therapy for anti‐MDA5 antibody‐positive dermatomyositis‐rapidly progressive interstitial lung disease
2023 · Kenichiro Hata, Takuya Kotani, et al. · International Journal of Rheumatic Diseases · 14
Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis
2018 · Nao Tokai, Shuzo Yoshida, et al. · PLoS ONE · 14
PDF
Efficacy and safety of combination therapy with prednisolone and oral tacrolimus for progressive interstitial pneumonia with systemic sclerosis: A retrospective study
2018 · Junichi Konma, Takuya Kotani, et al. · Modern Rheumatology · 13
Association of M2 Macrophages, Th2, and B Cells With Pathomechanism in Microscopic Polyangiitis Complicated by Interstitial Lung Disease
2022 · Shogo Matsuda, Takuya Kotani, et al. · The Journal of Rheumatology · 12
Newly diagnosed ANCA-associated vasculitis after COVID-19 infection: a case report
2023 · Kazuhiro Kitamoto, Yasushi Tanaka, et al. · Journal of Medical Case Reports · 10
PDF
Effects of denosumab on rheumatic diseases and refractory glucocorticoid-induced osteoporosis: a prospective study
2021 · Takaaki Ishida, Shuzo Yoshida, et al. · Archives of Osteoporosis · 8
A case of clinically mild encephalitis/encephalopathy with a reversible splenial lesion associated with anti-glutamate receptor antibody
2011 · Youhei Fujiki, Hideto Nakajima, et al. · Rinsho Shinkeigaku · 7
PDF
Correction: Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis
2019 · Nao Tokai, Shuzo Yoshida, et al. · PLoS ONE · 6
PDF
A successful plasma exchange in bridging to rituximab for severe neuropsychiatric lupus and lupus nephritis with viral infections and aspiration pneumonia
2023 · Maki Kagitani, Youhei Fujiki, et al. · Modern Rheumatology Case Reports · 5
Systemic myositis due toCampylobacterinfection
2014 · Y Fujiki, T Kotani, et al. · Scandinavian Journal of Rheumatology · 5
Congenital cytomegalovirus infection after maternal primary infection in a patient with systemic lupus erythematosus: A case report and literature review
2022 · Eri Nakamura, Kentaro Isoda, et al. · Lupus · 3
Efficacy of discontinuing risedronate for patients with systemic lupus erythematosus: a prospective study
2018 · T Ishida, S Yoshida, et al. · Lupus · 3
Long-term outcomes remain unchanged despite reduced glucocorticoid exposure in ANCA-associated vasculitis: the multicentre REVEAL cohort study
2026 · Mayu Shiomi, Ryu Watanabe, et al. · Frontiers in Immunology · 2
PDF
Acute heart failure due to fulminant eosinophilic myocarditis with mononeuritis: eosinophilic granulomatosis with polyangiitis requiring cardiac multimodality imaging and systemic evaluation: a case report
2025 · Jun-ichi Noiri, Hiroki Matsuzoe, et al. · European Heart Journal - Case Reports · 2
PDF
Works count: 35
Citation count: 446
H-index: 13
I10-index: 16
Year
Topic
Type